Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma.

Hassoun H, Reich L, Klimek VM, Dhodapkar M, Cohen A, Kewalramani T, Zimman R, Drake L, Riedel ER, Hedvat CV, Teruya-Feldstein J, Filippa DA, Fleisher M, Nimer SD, Comenzo RL.

Br J Haematol. 2006 Jan;132(2):155-61.

PMID:
16398649
2.

Thalidomide and dexamethasone: therapy for multiple myeloma.

Kumar S, Rajkumar SV.

Expert Rev Anticancer Ther. 2005 Oct;5(5):759-66. Review.

PMID:
16221046
3.

Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.

Badros A, Goloubeva O, Dalal JS, Can I, Thompson J, Rapoport AP, Heyman M, Akpek G, Fenton RG.

Cancer. 2007 Sep 1;110(5):1042-9. Review.

4.

Therapeutic application of thalidomide in multiple myeloma.

Kyle RA, Rajkumar SV.

Semin Oncol. 2001 Dec;28(6):583-7. Review.

PMID:
11740813
5.

A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma.

von Lilienfeld-Toal M, Hahn-Ast C, Furkert K, Hoffmann F, Naumann R, Bargou R, Cook G, Glasmacher A.

Eur J Haematol. 2008 Oct;81(4):247-52. doi: 10.1111/j.1600-0609.2008.01121.x. Epub 2008 Jul 10. Review.

6.

Lenalidomide: patient management strategies.

Hussein MA.

Semin Hematol. 2005 Oct;42(4 Suppl 4):S22-5. Review.

PMID:
16344098
7.

Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.

Dimopoulos MA, Tsatalas C, Zomas A, Hamilos G, Panayiotidis P, Margaritis D, Matsouka C, Economopoulos T, Anagnostopoulos N.

Semin Oncol. 2003 Apr;30(2):265-9. Review.

PMID:
12720150
8.

[Testicular involvement in IgD multiple myeloma].

Kawauchi K, Ogasawara T, Yasuyama M, Ohkawa S, Aiba M.

Rinsho Ketsueki. 2001 Nov;42(11):1128-33. Review. Japanese.

PMID:
11808083
9.

Thrombotic complications of myeloma therapy.

Zonder JA.

Hematology Am Soc Hematol Educ Program. 2006:348-55. Review.

PMID:
17124082

Supplemental Content

Support Center